- Contract Awards
Moderna (Nasdaq: MRNA) has received a potential $1.74 billion contract to initially produce and deliver 66 million doses of its COVID-19 vaccine booster candidate to the U.S. government. The contract calls for the delivery of the initial doses in 2022 and includes options for the government to buy 234 million more doses of Moderna’s mRNA-1273.222...